Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Löst diese riesige Entdeckung die Kupferkrise der KI? So ändert sich die Rechnung durch diesen Explorer!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EGK4 | ISIN: CA00258V3083 | Ticker-Symbol: 36N
Frankfurt
15.01.25
08:19 Uhr
7,900 Euro
-0,100
-1,25 %
1-Jahres-Chart
ABAXX TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
ABAXX TECHNOLOGIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
7,9008,05015:42
PR Newswire
456 Leser
Artikel bewerten:
(2)

Eventus and Abaxx: Abaxx Exchange Turns to Eventus for Trade Surveillance Platform to Support New Marketplace

Finanznachrichten News

NEW YORK and SINGAPORE, July 9, 2024 /PRNewswire/ -- Eventus, a leading provider of comprehensive, at-scale trade surveillance software, and Abaxx Technologies, a financial software and market infrastructure company and majority shareholder of Abaxx Singapore Pte Ltd. ("Abaxx Singapore"), the owner of Abaxx Commodity Exchange and Clearinghouse, announces that Abaxx Exchange has selected Eventus to provide the trade surveillance platform for the new marketplace. Abaxx has deployed the Validus platform as the foundation of its market surveillance program.


Open for trading as of June 28, 2024, and based in Singapore, Abaxx offers global futures on energy, metals and other energy transition focused commodities, beginning with liquified natural gas (LNG) and carbon, soon to be followed by solutions for battery metals.

Dan McElduff, Abaxx Exchange President, Strategy and Development, said: "As the first new regulated exchange and clearinghouse focused on physical commodities and built from the ground up in over a decade, Abaxx requires a market surveillance tool that is robust, customizable and scalable, yet quick and easy to implement. Eventus' Validus platform offers the flexibility we were looking for, supported by an experienced and responsive team guiding Abaxx in the deployment of the solution with ease. The user-centric features of Validus provide Abaxx with strong workflow automation, and better focus and control over our surveillance responsibilities of the market."

Eventus CEO Travis Schwab said: "We are incredibly honored that Abaxx has entrusted our team to provide the backbone of its critical trade surveillance function through the Validus platform. The innovative commodity exchange has generated significant interest in the industry. Market integrity is a high priority for the exchange, and Abaxx will benefit from our expertise and high-performance surveillance technology used by marketplaces and leading financial institutions across the globe."

About Eventus
Eventus provides state-of-the-art, at-scale trade surveillance software across all lines of defense. Its powerful, award-winning Validus platform is easy to deploy, customize and operate across equities, options, futures, foreign exchange (FX), fixed income and digital asset markets. Validus is proven in the most complex, high-volume, and real time environments of Eventus' rapidly growing client base, including tier-1 banks, broker-dealers, futures commission merchants (FCMs), proprietary trading groups, market centers, buy-side institutions, energy and commodity trading firms, and regulators. Clients rely on the platform, coupled with the firm's responsive support and product development, to overcome its most pressing trade surveillance regulatory challenges. For more, visit www.eventus.com.

About Abaxx Technologies
Abaxx is building Smarter Markets - markets empowered by better financial technology and market infrastructure to address our biggest challenges, including the energy transition. In addition to developing and deploying financial technologies that make communication, trade, and transactions easier and more secure, Abaxx is a majority-owner of Abaxx Exchange and Abaxx Clearing, subsidiaries recognized by MAS as an RMO and ACH, respectively.

Abaxx Exchange and Abaxx Clearing are a Singapore-based commodity futures exchange and clearinghouse, introducing centrally cleared, physically deliverable commodities futures and derivatives to provide better price discovery and risk management tools for the commodities critical to our transition to a lower-carbon economy.

For more information please visit abaxx.tech, abaxx.exchange and smartermarkets.media.

Abaxx

Logo - https://mma.prnewswire.com/media/635481/Eventus_Logo.jpg
Logo - https://mma.prnewswire.com/media/2456426/Abaxx_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/abaxx-exchange-turns-to-eventus-for-trade-surveillance-platform-to-support-new-marketplace-302191635.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.